Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer

Clinical trial NCT00922896 · COMPLETED

Trial details

NCT number: NCT00922896
Sponsor: Gyeongsang National University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2009-06-01
Primary completion: 2010-08-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.